Tilray Brands, Inc.
Long
Mis à jour

Buy $TLRY - NRPicks 14 Mar

302
Tilray, Inc. is dedicated to the research, cultivation, processing and distribution of medical cannabis. The company offers its products to patients, doctors, clinics, pharmacies, governments and hospitals.

The Ministry of Health and the New Zealand Medicinal Cannabis Agency grant Tilray the first approval under the new Medicinal Cannabis Plan to launch medicinal cannabis products across the country, which will undoubtedly have a major impact on revenue of the company.

During the week, most sectors showed a recovery, however, the marijuana companies had a controlled upside and this is likely to continue. We consider that Tilray is in the middle of its journey.

Technical:
- Average RSI levels
- Buying force 143M buying volume last week.
- Bounce on MA100
Trade fermée: ordre d’arrêt atteint
23 Mar

Clause de non-responsabilité

Les informations et les publications ne sont pas destinées à être, et ne constituent pas, des conseils ou des recommandations en matière de finance, d'investissement, de trading ou d'autres types de conseils fournis ou approuvés par TradingView. Pour en savoir plus, consultez les Conditions d'utilisation.